ロード中...
Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype
BACKGROUND: The efficacy of cell transplantation in heart failure is reportedly modest, but adjuvant drugs combined with cell therapy may improve this efficacy. Peroxisome proliferator-activated receptor (PPAR)γ, one of the hypoglycemic medicine for diabetes mellitus, reportedly enhances cytokine pr...
保存先:
| 出版年: | Cardiovasc Diabetol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6431071/ https://ncbi.nlm.nih.gov/pubmed/30902059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0829-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|